Relay Therapeutics, a clinical-stage precision medicine company focused on cancer and genetic diseases, announced it will participate in two investor fireside chats in June 2026: the Jefferies Global Healthcare Conference on June 3 and the Goldman Sachs Global Healthcare Conference on June 8. These presentations will be webcast live and accessible via the company's website, offering investors insights into its clinical programs, including its lead drug candidate zovegalisib, currently in Phase 3 trials for metastatic breast cancer. This engagement highlights Relay's efforts to increase visibility and investor confidence as it advances its pipeline of targeted therapies.
Micron Technology CEO Sanjay Mehrotra sold nearly $36 million worth of company stock last week, offloading 37,439 shares at an average price of $960.38 each. This sale was part of a pre-arranged trading plan and reduces his direct holdings by about 8...
The global mobile forensics market is projected to grow from $5.72 billion in 2026 to $9.99 billion by 2031, at an 11.8% CAGR. Growth is fueled by increasing mobile ecosystem complexity, widespread use of encrypted apps, and demand for integrated for...
Costco's stock increased by about 2% following strong May sales results, with net sales up 14.5% year-over-year to $24.01 billion. U.S. comparable sales rose 13.7%, and digitally enabled sales jumped 21.1%, highlighting the company's growing e-commer...
Space stocks are sharply down this week, with Redwire, Momentus, and Rocket Lab falling over 20% due to SpaceX's reduced IPO valuation and a failed short squeeze on Virgin Galactic. SpaceX set its IPO price at $135 per share, valuing the company at $...
Global Clean Energy, Inc. has launched ResilientIQ™, an AI platform designed to improve emergency management by providing faster, cited operational guidance. The platform is now moving from development to commercial engagement with active demonstrati...
